Tag: Medicine
-
Transitional Care Practice Reduces Costs
A transitional care practice at Northwestern Memorial Hospital helped reduce healthcare costs compared to traditional discharge services, according to a Northwestern Medicine study.
-
Improving Interferon Therapy for Blood Cancers
Investigators have discovered a novel signaling pathway in interferons that suppresses their anti-tumor response in patients with a particular type of blood cancer.
-
New Leadership in Faculty Affairs
William Lowe, Jr., MD, the Thomas D. Spies Professor of Genetic Metabolism, has announced that he will be stepping down as vice dean for Academic Affairs effective September 1.
-
Investigators Identify Potential Therapeutic Target for Pancreatic Cancer
Investigators discovered that decreased expression of the G alpha 13 protein in mice and human pancreatic tumors promotes tumor growth, according to recent findings.
-
Northwestern Investigates COVID-19: Antibodies, Global Surveillance, Women in Research
Northwestern Medicine continues to help advance the understanding of the COVID-19 pandemic and its widespread impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research to highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.
-
Pursuing Deeper Understanding about the Most Common Type of Heart Failure
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
-
Director of Center for Aging and HIV: Increasing Patient Lifespan and ‘Healthspan’
Frank Palella, MD, is working towards increasing the lifespan and “healthspan” of people living with HIV through research, education and patient care as director of the new Potocsnak Center for Aging and HIV.
-
Investigating Prevalence Risk of Familial Heart Failure
Idiopathic dilated cardiomyopathy (DCM) was found to have a familial etiology in 30 percent of individuals diagnosed with DCM, and the overall risk for a family member of developing DCM was nearly 20 percent by the age of 80.
-
Drug Combination Fails to Improve Outcomes in Influenza
A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
-
Novel Combination Therapy May Extend Pancreatic Cancer Survival
A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.
